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EVIDENCE B R I E F
 “Expanding options and choices for the 
poorest women and adolescent girls 
is the most important thing we do. By 
empowering them to make their own 
decisions about the timing and spacing 
of pregnancies, we open an important 
pathway towards their economic security 
and independence, as well as the realization 
of all the Sustainable Development Goals.”
—Dr. Natalia Kanem, Executive Director of the United 
Nations Population Fund
Approximately 214 million women of reproductive age in developing 
regions who want to avoid pregnancy are not using a modern 
contraceptive method and are considered to have an unmet need 
(1). Expanding contraceptive options for voluntary family planning is 
critical to addressing this need for several reasons. First, needs may 
vary throughout the reproductive life-course, and individuals have 
different desires depending on their personal and family context; 25% of 
women want to space their pregnancies, reflecting a need for shorter-
term or reversible methods, compared with 14% of women who wish 
to cease childbearing and thus limit future pregnancies (2). Second, 
some women discontinue contraceptive use even though they want to 
avoid pregnancy (3, 4). Reasons for discontinuation include side effects, 
myths, contraceptive failure, or the service environment, including 
service quality and availability of a sufficient choice of methods (4). 
Expanding contraceptive 
choice 
POLICY AND PROGRAMME 
CONSIDERATIONS
Establish and maintain well-
functioning supply chains for an 
expanded choice of contraceptives:
 Introduce new contraceptive 
technologies to satisfy the 
diverse preferences of women 
and their partners. 
 Overcome access barriers 
to existing methods such as 
adverse economic and social 
circumstances, including gender 
norms.
 Maximize the potential of 
expanded contraceptive choice 
by ensuring a robust supply 
chain and improving provider 
training and counselling.
FAMILY PLANNING
Use of modern contraception increases when more methods 
become available: analysis of evidence from 1982–2009
Having a wide choice of contraceptives will meet the needs 
of some discontinuers if they have the option of switching; 
broadened method availability can reduce contraceptive 
discontinuation by 8% (5). Third, three-fifths of women 
(62%) with unmet need have never used contraception (5), 
and a wider range of options may be appealing enough 
to some women to try contraception. The addition of one 
new method to the available method mix can increase 
contraceptive prevalence by as much as eight percentage 
points (6). Finally, expanding method choice can ensure 
that methods are available for those wanting to protect 
against both pregnancy and sexually transmitted infections 
including HIV.
CONSIDERATIONS FOR EXPANDING 
CONTRACEPTIVE CHOICE
 STRATEGIES TO EXPAND  
CONTRACEPTIVE OPTIONS 
Proven strategies to expand contraceptive options 
include introducing new contraceptives to family planning 
programmes, expanding access to existing methods, and 
expanding the provider base.
Introduce new contraceptive technologies 
New contraceptive technologies have been developed 
to satisfy the diverse preferences of women and their 
partners and to overcome the challenges of providing some 
methods in low-resource settings. For example, studies 
have shown that DMPA subQ in Uniject (Sayana® Press) 
can be provided by grassroots health cadres and by users 
themselves, thus reducing reliance on healthcare systems 
(7, 8). Studies also suggest that women find Sayana® Press 
to be a feasible and acceptable choice of contraception 
which is currently being introduced,  scaled- up, or piloted 
in more than 15 FP2020 countries (9, 10, 11, 12). Other new 
product categories include vaginal rings that women can 
insert themselves, and can be offered through various 
supply outlets ranging from drug stores to tertiary-level 
facilities (13, 14). The levonorgestrel (LNG) intrauterine 
system and emerging technologies such as a biodegradable 
implant, longer-lasting injectables, microCHIPS remote- 
controlled contraceptives, and multipurpose prevention 
technologies (MPTs) for contraception and HIV and/or STI 
prevention hold the promise of an even wider choice of 
methods. In addition to vasectomy and tubal ligation, more 
affordable, safer, and simpler permanent contraceptive 
options for women and men should also be considered, 
given that there is substantial unmet need for limiting.
Expand access to existing methods
Overcoming barriers to existing methods such as policy, 
geography, and adverse economic and social circumstances 
including restrictive gender norms will expand access 
to existing methods. For example, expanding access 
to implants through mobile outreach programmes and 
reducing the price through a volume guarantee resulted 
in significant increases in use (15, 16). Similarly, socio-
cultural barriers to providing services to adolescents can 
be overcome in many ways including via comprehensive 
sexuality education, gender-transformative programming, 
adolescent-friendly services, and providing contraceptives 
through a variety of service outlets (17).
Expand provider base
Task-shifting or task-sharing is the redistribution of 
contraceptive counselling and service provision among 
different health worker cadres. For example, enabling 
community health workers (CHWs) to provide injectables, 
like Sayana® Press, and implants has expanded access to 
and increased voluntary use of both methods in many 
countries (18, 19, 20). Expanding provision to drugstore 
and pharmacy staff has  also increased access to oral 
contraceptive pills, including those for emergency 
contraception, and injectables, especially for underserved 
populations (21). Increasing the variety of providers allows 
users to choose convenient and accessible service delivery 
points. Finally, user-initiated contraceptives like fertility 
awareness methods and pills are increasingly empowering 
women’s independent use of contraceptives, further 
expanding access.
 MAXIMIZING THE POTENTIAL 
OF EXPANDING CONTRACEPTIVE 
OPTIONS
The following actions are essential to ensuring that these 
strategies are successful and lead to greater contraceptive 
access, uptake, and continuation: 
 
Ensure a robust supply chain 
Ensuring availability of contraceptive supplies at points 
of care that are close to clients is essential. Robust 
supply chains that eliminate stock- outs and engage 
multiple manufacturers to ensure high-quality, low- 
cost contraceptive products are critical for uptake and 
continuation (22).
Improve provider training and counselling 
Providers should be trained in client-oriented service 
provision for a range of methods in both clinical and 
community settings (23, 24). Comprehensive and accurate 
counselling allows clients to learn more about contraceptive 
options, including managing side effects, benefits, and 
possibility of switching (25). Users can then choose a 
contraceptive that best suits their need, or switch methods 
if they so desire. Addressing lack of provider knowledge 
of underutilized methods, like no-scalpel vasectomy, could 
also increase contraceptive access (26).
Generate demand
Even with a well-informed provider base, an expanded 
method mix can only reach its full potential with continued 
demand from users. For example, despite vasectomy’s 
well-recognized benefits including high effectiveness, 
convenience, permanence, relative ease of provision, 
few side effects, and high levels of satisfaction, use of 
the method is plagued by low demand among men (27). 
Family planning program experience suggests that demand 
generation through media campaigns and mobile services 
can increase contraceptive use and intention to use modern 
contraceptives by improving community
and individual knowledge and attitudes and promoting 
partner communication (28). Satisfied contraceptive users 
who speak to others about their experience are also highly 
effective in generating demand and changing social norms 
related to voluntary family planning (28).
ACHIEVING FP2020 GOALS  
AND BEYOND
Expanding the range of contraceptive options helps 
individuals to make choices appropriate to their needs and 
circumstances, allows them to switch from one method 
to another if desired, and reflects a programme focus on 
quality and rights. 
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